Physicians at Navicent Health Offer Innovative Approach for Patients with Peripheral Artery Disease
Physicians at The Medical Center, Navicent Health (MCNH) are utilizing new and innovative technology, the Diamondback 360® Extended Length Peripheral Orbital Atherectomy Device (OAD) from Cardiovascular Systems, Inc. (CSI®) to treat patients with peripheral artery disease (PAD).
PAD affects as many as 18 million Americans and is a circulatory condition in which narrowed and hardened blood vessels reduce blood flow to the limbs. If left untreated, PAD could lead to limb amputation. When surgery is needed, PAD can be treated by atherectomy – a minimally invasive procedure to open blocked arteries by using a device on the end of a catheter to remove built up plaque. Then, a balloon angioplasty or stent procedures is completed to restore blood flow. This procedure is frequently performed by accessing the artery through the groin. However, with new OAD extended length technology at MCNH, physicians are given an alternative access point in which the artery can be reached by going through the wrist.
“This technology is a huge win for patients with PAD. Accessing the artery from the wrist, rather than the groin, is much less invasive, leading to a faster recovery time and an overall better patient experience. Patients will experience the ability to walk less than an hour post-procedure and shorter hospital stays, on average,” said Michael Klyachkin, MD, vascular surgeon with Vascular Institute, Navicent Health Physician Group.
Dr. Klyachkin became the first physician in the Macon area to use this innovative new procedure on October 29, 2019.
“We at Navicent Health are proud to be the first in the area to adopt this new technology for the treatment of peripheral artery disease. Navicent Health is committed to providing the safest and most advanced treatment options to enhance our patients’ experiences and outcomes,” said Tom Oliver, MD, Chief Clinical Officer for Navicent Health.
What is Peripheral Artery Disease (PAD)?
As many as 18 million Americans, most over age 65, suffer from PAD, which is caused by the accumulation of plaque in peripheral arteries reducing blood flow. Symptoms include leg pain when walking or at rest. Left untreated, PAD can lead to severe pain, immobility, non-healing wounds and eventually limb amputation. With risk factors such as diabetes and obesity on the rise, the prevalence of PAD is growing at double-digit rates. Literature shows that Balloon angioplasty and stents can have significant shortcomings in treating hard, calcified lesions. Stents are prone to fractures and high recurrence rates, and treatment of hard, calcified lesions often leads to vessel damage and suboptimal results.
Millions of patients with PAD may benefit from treatment with orbital atherectomy utilizing the Diamondback 360® and Stealth 360® Peripheral Orbital Atherectomy Systems, which are minimally invasive catheter systems developed and manufactured by CSI. These systems use a diamond-coated crown, attached to an orbiting shaft, which sands away plaque while preserving healthy vessel tissue — a critical factor in preventing reoccurrences.
For more information, please visit www.navicenthealth.org.
The Editorial Team at Lake Oconee Health is made up of skilled health and wellness writers and experts, led by Daniel Casciato who has over 25 years of experience in healthcare writing. Since 1998, we have produced compelling and informative content for numerous publications, establishing ourselves as a trusted resource for health and wellness information. We aim to provide our readers with valuable insights and guidance to help them lead healthier and happier lives.
